Abreu VC

Carletti L

Dias LH

Giovelli RA

Lendrem DW

Miyamoto ST

Natour J

Ng W-F

Perez AJ

Serrano EV

Subtil AM

Trennel M

Valim V

\ua9 2019, Springer-Verlag GmbH Germany, part of Springer Nature. Objective: The aim of this study was to evaluate the safety and effectiveness of a supervised walking program in women with primary Sj\uf6gren’s syndrome (pSS). Methods: Forty-five sedentary women fulfilling the American European Consensus Criteria for pSS were randomized to a training group (TG, n = 23) or control group (CG, n = 22). Patients in the TG were submitted to supervise walking three times a week for 16 weeks. The patients of the CG were instructed to not perform any kind of regular physical exercise. Physical fitness [maximum oxygen uptake (VO2max) and distance], EULAR Sj\uf6gren’s Syndrome Disease Activity Index (ESSDAI), hematological tests, and Medical Outcomes Study 36 (SF-36) were assessed at baseline and week 16. In addition, EULAR Sj\uf6gren’s Syndrome Patient Reported Index (ESSPRI), Functional Assessment of Chronic Illness Therapy Fatigue Subscale (FACIT-fatigue), and Beck Depression Inventory (BDI) were measured prior to intervention, after 8 and 16 weeks. Patient global assessment of response to therapy was completed at the final assessment. An intent-to-treat analysis was performed. Results: After 16 weeks, the mean change of VO2max (ml/kg/min), distance, and FACIT-fatigue were higher in the TG than in the CG (p = 0.016, p = 0.043 and p = 0.030, respectively). Improved cardiorespiratory fitness was associated with improvements in fatigue scores and physical components of quality of life (SF-36). Furthermore, improved fatigue scores were associated with reduced depression and improvements in the physical and mental components of SF-36. Overall, 95.4% of patients in the TG rated themselves as clinically improved versus 62% of the patients in the CG (p = 0.049). There was no flare in disease activity and no serious adverse events with exercise. Conclusions: This supervised walking program was demonstrated to be feasible and safe with improvements in cardiorespiratory fitness, exercise tolerance, fatigue, and patient perception of improvement in pSS patients. Trial registration: Clinical Trials.gov ID, number NCT02370225

Newcastle University E-Prints

Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sj\uf6gren’s syndrome: a randomized-controlled trial

https://eprint.ncl.ac.uk/fulltext.aspx?url=254174/C62B4EF6-35CD-4808-A9D8-BFA2D6777B0F.pdf&pub_id=254174

Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sj\uf6gren’s syndrome: a randomized-controlled trial

Abstract

Similar works

Full text

Available Versions

Newcastle University E-Prints